Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 43,738Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alembic Pharmaceuticals Limited

02 1MSN Life Sciences Private Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 625115-55-1 / Riociguat API manufacturers, exporters & distributors?

Riociguat manufacturers, exporters & distributors 1

87

PharmaCompass offers a list of Riociguat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Riociguat manufacturer or Riociguat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Riociguat manufacturer or Riociguat supplier.

PharmaCompass also assists you with knowing the Riociguat API Price utilized in the formulation of products. Riociguat API Price is not always fixed or binding as the Riociguat Price is obtained through a variety of data sources. The Riociguat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Riociguat

Synonyms

625115-55-1, Adempas, Bay 63-2521, Riociguat (bay 63-2521), Bay-63-2521, Ru3fe2y4xi

Cas Number

625115-55-1

Unique Ingredient Identifier (UNII)

RU3FE2Y4XI

About Riociguat

Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for the treatment of patients with inoperable CTEPH (chronic thromboembolic pulmonary hypertension), or persistent/recurrent PH (pulmonary hypertension) after pulmonary endarterectomy in WHO FC II or III. Riociguat is marketed under the brand Adempas by Bayer HealthCare Pharmaceuticals. Treatment with riociguat costs USD $7,500 for 30 days of treatment.

Bay 63-2521,Riociguat Manufacturers

A Bay 63-2521,Riociguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bay 63-2521,Riociguat, including repackagers and relabelers. The FDA regulates Bay 63-2521,Riociguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bay 63-2521,Riociguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Bay 63-2521,Riociguat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Bay 63-2521,Riociguat Suppliers

A Bay 63-2521,Riociguat supplier is an individual or a company that provides Bay 63-2521,Riociguat active pharmaceutical ingredient (API) or Bay 63-2521,Riociguat finished formulations upon request. The Bay 63-2521,Riociguat suppliers may include Bay 63-2521,Riociguat API manufacturers, exporters, distributors and traders.

click here to find a list of Bay 63-2521,Riociguat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Bay 63-2521,Riociguat NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bay 63-2521,Riociguat as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Bay 63-2521,Riociguat API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Bay 63-2521,Riociguat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Bay 63-2521,Riociguat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bay 63-2521,Riociguat NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Bay 63-2521,Riociguat suppliers with NDC on PharmaCompass.

Bay 63-2521,Riociguat Manufacturers | Traders | Suppliers

Bay 63-2521,Riociguat Manufacturers, Traders, Suppliers 1
47

We have 2 companies offering Bay 63-2521,Riociguat

Get in contact with the supplier of your choice:

  1. Alembic Pharmaceuticals Limited
  2. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.